• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.33% Nasdaq Up 1.33%

    Argos Therapeutics, Inc. (ARGS)

    -NasdaqGM
    6.13 Up 0.51(9.07%) Jun 30, 4:00PM EDT
    Prev Close:5.62
    Open:5.61
    Bid:6.15 x 700
    Ask:7.06 x 200
    1y Target Est:12.67
    Beta:N/A
    Earnings Date:Aug 10 - Aug 15 (Est.)
    Day's Range:5.51 - 6.15
    52wk Range:1.61 - 13.97
    Volume:261,140
    Avg Vol (3m):425,677
    Market Cap:158.72M
    P/E (ttm):N/A
    EPS (ttm):-3.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARGS

    Comparison

    Symbol% ChgMkt Cap
    ARGSUp 9.07%158.72M
    PFEUp 0.57%213.54B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):299.41
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.74
    Quarterly EPS Est (Jun-16) :-0.43
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback